Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
2022 FDA approval of new drug transcript
>> article
2022 FDA approval of new drug transcript
Editor:xuezhe Clicks:
0
Date:2023-1-12 13:33:58
Keyword:
FDA
Healthoo Information:
2022 FDA approval of new drug transcript
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
The first in the world! Huadong Pharmaceuticals new FRα target ADC was...
FDA Success Stories CDE Recommendations: How MIDD Accelerates Drug Dis...
The worlds first Upadatinib extended-release tablets approved by FDA f...
Sodium thiosulfate has been approved by the FDA to reduce hearing loss...
FDA approves ibrutinib for chronic graft-versus-host disease in childr...
FDA Issues Drug Statement, Mercks Hypoglycemic Drug Sitagliptin Detect...
Upadatinibs launch accelerated: Crohns disease has simultaneously subm...
FDA Breakthrough Therapy Designation for Topical Vitamin A Derivatives...
AstraZenecas Ultomiris Third Indication Approved by US FDA!
New Drugs Approved by FDA in February 2022
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
